S
Market Data
$19.05+$2.46 (+14.83%)
SMMT · Last trade
Prev Close
$16.59
Range (30d)
$14.94 – $19.05
Recent Filings
- 10-K16.3 MBSummit Therapeutics Inc.Feb 23, 4:10 PM ET·0001599298-26-000015
- 8-K6.2 MBSummit Therapeutics Inc.Feb 23, 4:07 PM ET·0001599298-26-000014
- 8-K1.5 MBSummit Therapeutics Inc.Jan 29, 7:35 AM ET·0001599298-26-000006
- 8-K5.8 MBSummit Therapeutics Inc.Jan 12, 7:43 AM ET·0001599298-26-000004
- 8-K2.1 MBSummit Therapeutics Inc.Nov 7, 9:23 AM ET·0001599298-25-000166
- 8-K502.6 KBSummit Therapeutics Inc.Oct 22, 8:56 AM ET·0001193125-25-245790
- 10-Q5.6 MBSummit Therapeutics Inc.Oct 20, 7:51 AM ET·0001599298-25-000159
- 8-K12.4 MBSummit Therapeutics Inc.Oct 20, 7:28 AM ET·0001599298-25-000156
- 8-K5.9 MBSummit Therapeutics Inc.Sep 8, 7:45 AM ET·0001599298-25-000137
- 8-K3.8 MBSummit Therapeutics Inc.Aug 11, 5:13 PM ET·0001599298-25-000128
Insiders
10- Anand BhaskarChief Accounting Officer
- Booth Robert F.Director
- Cesano AlessandraDirector
- Clark Kenneth ADirector
- Dhingra AnkurChief Financial Officer
- Donaldson Michael PaulChief Financial Officer
- DUGGAN ROBERT WDirector, Co-Chief Executive Officer, 10% Owner
- Erdtmann Rainer MDirector
- Gayko UrteDirector
- Graham CamillaChief Clinical Affairs Officer
Tickers
Addresses
business
601 BRICKELL KEY DRIVE SUITE 1000
MIAMI, FL, 33131
mailing
601 BRICKELL KEY DRIVE SUITE 1000
MIAMI, FL, 33131
Former Names
- Summit Therapeutics plc2020-09-17
- Summit Corp plc2015-01-30